Cellular senescence and senotherapies in the kidney: current evidence and future directions

MH Docherty, DP Baird, J Hughes… - Frontiers in …, 2020 - frontiersin.org
… In a series of human renal transplant biopsies, all biopsy specimens showed P16 INK4A
staining in the nuclei of distal tubules and collecting duct but staining was also present in …

Delayed graft function in kidney transplant: risk factors, consequences and prevention strategies

C Ponticelli, F Reggiani, G Moroni - Journal of personalized medicine, 2022 - mdpi.com
… Delayed graft function is a frequent complication of kidney transplantation that requires
dialysis in the first week posttransplant. Materials and Methods. We searched for the most …

Historic overview of genetic engineering technologies for human gene therapy

R Tamura, M Toda - Neurologia medico-chirurgica, 2020 - jstage.jst.go.jp
Future Direction … Longterm safety and efficacy of factor IX gene therapy in hemophilia B. N
Engl J Med 371: 1994–2004, … Update on the safety and efficacy of retroviral gene therapy for …

An update on the current state of management and clinical trials for IgA nephropathy

CK Cheung, A Rajasekaran, J Barratt… - Journal of clinical …, 2021 - mdpi.com
… area and explore future directions for translational research. … insights into a certain drug’s
effectiveness, although this is an invasive … a deceased-donor kidney transplant within 72 h after …

The glomerular filtration barrier: a structural target for novel kidney therapies

IS Daehn, JS Duffield - Nature Reviews Drug Discovery, 2021 - nature.com
… have emerged as potential therapeutic targets. Circulating proteins that contribute to GFB
breakdown following kidney transplantation may also be targeted for therapeutic benefit. Such …

[HTML][HTML] … for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy

AS Kanate, NS Majhail, BN Savani, C Bredeson… - … Marrow Transplantation, 2020 - Elsevier
… Prospective studies reporting safety and efficacy of CD19-directed CAR-T therapy in other B
… potentially demonstrates safety and efficacy of IECT, the evidence will be critically reviewed …

What therapeutic regimen will be optimal for initial clinical trials of pig organ transplantation?

M Bikhet, H Iwase, T Yamamoto, A Jagdale… - …, 2021 - journals.lww.com
… We administer this on day −3 (ie, 3 d before the kidney transplant [day 0]) to deplete circulating
T … Preliminary evidence of safety and efficacy in SLE patients, but larger sample size is …

Posttransplant lymphoproliferative disorder following kidney transplantation: a review

B Sprangers, LV Riella, D Dierickx - American Journal of Kidney Diseases, 2021 - Elsevier
… -line therapy fails, and taking into account increased toxicity in transplant recipients, new
therapies combining high efficacy … Although very promising new treatment options have been …

[HTML][HTML] Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the transplantion society working …

CA Schinstock, RB Mannon, K Budde, AS Chong… - …, 2020 - journals.lww.com
… AMR, despite the weakness of evidence in support of efficacy. In particular, their ability …
new agents and clinical trials are needed urgently. Future directions in this field will require new

Failure to advance access to kidney transplantation over two decades in the United States

JD Schold, S Mohan, A Huml, LD Buccini… - Journal of the …, 2021 - journals.lww.com
… To evaluate the longitudinal pattern of access to kidney transplantation over the past two …
or placed on a transplant waiting list from 1997 to 2016 in the United States Renal Data System. …